ClinicalTrials.gg
CompletedNCT07865104Updated Oct 8, 2026

Addiction Psychoeducation for Canadian Muslims

An interventional study of Culturally sensitive addiction psychoeducation program and Secular in Knowledge Gaps, Attitudes and Stigma of Mental Illness, sponsored by Centre for Addiction and Mental Health. Completed at 1 site in Canada. Open to participants aged 16 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-08.

Sponsored by Centre for Addiction and Mental Health · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 2 years 9 months after the study started (first participant enrolled Dec 2023, registered Sep 2026).
Updated Oct 8, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
187
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

The Canadian Muslim Addiction Program (C-MAP) was designed as a pilot randomized controlled study using quantitative and qualitative methods to evaluate culturally and spiritually adapted addiction psychoeducation. Its aim is to reduce addiction-related stigma by improving knowledge, attitudes toward addiction, and professional help-seeking among Canadian Muslims.

The protocol specifies a target sample of 200-300 participants aged 16 years or older, drawn from three populations: Muslim individuals with lived experience of addiction, family members of individuals with addiction, and members of the Muslim general public. Participants are randomly assigned in a 1:1 ratio to either C-MAP psychoeducation incorporating Islamic perspectives or a control program covering similar addiction topics without spiritually adapted content. The study involves a single virtual session, with questionnaires administered before and after the intervention.

Self-report measures assess addiction-related knowledge, attitudes, stigma, and help-seeking, while open-ended questions explore participants' experiences and the perceived contribution of Islamic content. The study also examines whether baseline spirituality is associated with improvements in outcomes. Findings are intended to inform refinement of the program and provide feasibility information and effect-size estimates for a larger trial.

02

Conditions studied

  • Knowledge Gaps
  • Attitudes
  • Stigma of Mental Illness
  • Help-seeking Intention

Browse trials for

03

In context

Behavior

404 studies on the registry are indexed under Behavior; 167 are open to participants now.

This study's enrollment of 187 is above the median of 120 across 316 interventional studies indexed under Behavior.

Browse Behavior studies →

Lead sponsor

Centre for Addiction and Mental Health is the lead sponsor of 339 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 16 years or older.
  • Self-identifies as belonging to one of the following three target populations:
  • Muslim individuals with lived experience of addiction, defined as self-reported lifetime substance use or problematic behaviours with difficulty stopping.
  • Muslim family members of individuals with addiction.
  • Muslim members of the general public who do not meet either of the preceding population definitions.

Exclusion criteria

Exclusion Criteria:

  • Does not belong to any of the specified target populations.
  • Unable to communicate in English.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
187 participants (actual)

Study arms

  • Experimental
    culturally and spiritually adapted addiction psychoeducation material

    Other: Culturally sensitive addiction psychoeducation program

  • Active comparator
    Secular addiction psychoeducation material

    Other: Secular

Interventions

  • OtherCulturally sensitive addiction psychoeducation program

    The Canadian Muslim Addiction Program (C-MAP) is a culturally and spiritually adapted addiction psychoeducation program for Muslim individuals with lived experience of addiction, family members of individuals with addiction, and members of the general public. It aims to reduce addiction-related stigma by increasing knowledge, improving attitudes toward addiction, and enhancing professional help-seeking. Participants receive the intervention during a single virtual study session through the secure Webex platform, with approximately 60-90 minutes devoted to the psychoeducation content. The content is organized into 17 short subtopics for each target population and addresses addictive substances and behaviors from an Islamic perspective. Topics include the causes and consequences of addiction, treatment options, harm reduction, and help-seeking. Evidence-based addiction information is integrated with Islamic perspectives, including the role of spiritual practices in treatment and

  • OtherSecular

    The control program addresses similar addiction psychoeducation subtopics to C-MAP but does not include spiritually adapted content.

06

What researchers measure

Primary outcomes

  1. Quantitative changes: Change in addiction-related knowledge comparing culturally sensitive with secular psychoeducation.

    Stigma-related knowledge is assessed using the Mental Health Knowledge Schedule (MAKS). The knowledge score is calculated by summing the first six items, each scored from 1 to 5, with reverse coding applied as appropriate. The minimum possible score is 6 and the maximum possible score is 30. Higher scores indicate greater stigma-related mental health knowledge and represent a better outcome. An increase from baseline indicates improvement.

    Time frame: baseline (pre-intervention) and immediately after the intervention

Secondary outcomes

  1. Qualitative evaluation: Participants' perceptions of C-MAP and its perceived influence on addiction-related stigma.

    Qualitative evaluation of participants' perceptions, feelings, and experiences of the program, particularly its perceived influence on addiction-related stigma, bias, and attitudes toward addiction. Four open-ended questions explore the contribution of Islamic content and additional experiences not captured by the quantitative questionnaires. Responses are collected in writing through Research Electronic Data Capture software (REDCap) or through an optional individual interview and analyzed using qualitative content analysis to identify overarching themes and subthemes, illustrated by supporting participant quotations.

    Time frame: Immediately after the intervention

Other outcomes

  1. Quantitative changes: Change in addiction-related help-seeking comparing culturally sensitive with secular psychoeducation.

    Help-seeking intentions are assessed using the Help Seeking Questionnaire (HSQ). Participants rate their likelihood of seeking help from specified sources on a scale ranging from 1, indicating extremely unlikely, to 7, indicating extremely likely. For ratings concerning professional help sources, higher scores indicate a greater intention to seek professional help and represent a better outcome. An increase from baseline indicates improvement.

    Time frame: baseline (pre-intervention) and immediately after the intervention

  2. Quantitative changes: Change in addiction-related internalized stigma following psychoeducation, comparing culturally sensitive with secular psychoeducation.

    Internalized substance-use stigma is assessed using the six-item Internalized Stigma Subscale of the Substance Use Stigma Mechanism Scale (SU-SMS). Each item is rated from 1, indicating strongly disagree, to 5, indicating strongly agree. The subscale score is calculated as the mean of the six item responses, with a minimum possible score of 1 and a maximum possible score of 5. Higher scores indicate greater internalized substance-use stigma and represent a worse outcome. A decrease from baseline indicates improvement

    Time frame: baseline (pre-intervention) and immediately after the intervention

  3. Quantitative changes: Change in addiction-related attitudes comparing culturally sensitive with secular psychoeducation.

    Attitudes toward seeking professional psychological help are assessed using the culturally adapted 20-item Attitude Towards Seeking Professional Psychological Help Scale (ATSPPHS). Each item is scored from 1 to 4. Item scores are summed after applying the appropriate reverse-coding, yielding a total score with a minimum of 20 and a maximum of 80. Higher scores indicate more favourable attitudes toward seeking professional psychological help for addiction and mental health concerns and represent a better outcome. An increase in the total score from baseline to immediately after the intervention indicates improvement.

    Time frame: baseline (pre-intervention) and immediately after the intervention

  4. Quantitative changes: Change in addiction-related attitudes comparing culturally sensitive with secular psychoeducation.

    Stigma-related intended behaviour is assessed using the Reported and Intended Behaviour Scale (RIBS). The intended-behaviour score is calculated by summing items 5-8, each scored from 1 to 5. The minimum possible score is 4 and the maximum possible score is 20. Higher scores indicate greater willingness to engage socially with individuals with mental health problems and represent a better outcome. An increase from baseline indicates improvement. The first four items describe previous or current contact and are not included in the intended-behaviour score.

    Time frame: baseline (pre-intervention) and immediately after the intervention

  5. Quantitative changes: Change in addiction-related stigma following psychoeducation, comparing culturally sensitive with secular psychoeducation.

    Perceived addiction-related stigma is assessed using the Perceived Stigma of Substance Abuse Scale (PSAS). This eight-item questionnaire measures participants' perceptions of society's attitudes toward individuals who have received treatment for substance use problems, including their social acceptance and perceived trustworthiness. Each item is rated from 1 (strongly disagree) to 4 (strongly agree). After reverse-scoring the positively worded items, responses are summed to produce a total score ranging from a minimum of 8 to a maximum of 32. Higher scores indicate greater perceived stigma and represent a worse outcome. A decrease in the total score indicates improvement. This was provided for the general public and families groups.

    Time frame: baseline (pre-intervention) and immediately after the intervention

  6. Quantitative changes: Change in addiction-related attitude, comparing culturally sensitive with secular psychoeducation.

    Attitudes toward individuals with addiction and addiction treatment are assessed using the Brief Substance Abuse Attitude Survey (BSAS). This 25-item questionnaire assesses beliefs about substance use problems, individuals affected by addiction, and approaches to treatment and recovery. Each item is rated on a five-point scale ranging from 1 (strongly disagree) to 5 (strongly agree). this was provided for families group only

    Time frame: baseline (pre-intervention) and immediately after the intervention

07

Study locations

1 site
  • CAMH
    Toronto, Ontario M6J1H4, Canada
08

References and documents

Publications

  • Elhai JD, Schweinle W, Anderson SM. Reliability and validity of the Attitudes Toward Seeking Professional Psychological Help Scale-Short Form. Psychiatry Res. 2008 Jun 30;159(3):320-9. doi: 10.1016/j.psychres.2007.04.020. Epub 2008 Apr 22. PubMed 18433879 ↗
  • Evans-Lacko S, Rose D, Little K, Flach C, Rhydderch D, Henderson C, Thornicroft G. Development and psychometric properties of the reported and intended behaviour scale (RIBS): a stigma-related behaviour measure. Epidemiol Psychiatr Sci. 2011 Sep;20(3):263-71. doi: 10.1017/s2045796011000308. PubMed 21922969 ↗
  • Al-Ghafri Q, Radcliffe P, Gilchrist G. Barriers and facilitators to accessing inpatient and community substance use treatment and harm reduction services for people who use drugs in the Muslim communities: A systematic narrative review of studies on the experiences of people who receive services and service providers. Drug Alcohol Depend. 2023 Mar 1;244:109790. doi: 10.1016/j.drugalcdep.2023.109790. Epub 2023 Jan 31. PubMed 36805826 ↗
  • Hassan AN, Agabani Z, Ahmed F, Shapiro B, Le Foll B. The Impact of religiosity/spirituality on slowing the progression of substance use: Based on the National Epidemiological Survey of Alcohol and Related Conditions (NESARC-III). Int J Soc Psychiatry. 2023 Sep;69(6):1399-1408. doi: 10.1177/00207640231162819. Epub 2023 Mar 23. PubMed 36951385 ↗
  • Hassan AN, Ragheb H, Malick A, Abdullah Z, Ahmad Y, Sunderji N, Islam F. Inspiring Muslim Minds: Evaluating a Spiritually Adapted Psycho-educational Program on Addiction to Overcome Stigma in Canadian Muslim Communities. Community Ment Health J. 2021 May;57(4):644-654. doi: 10.1007/s10597-020-00699-0. Epub 2020 Aug 25. PubMed 32844327 ↗

Study documents

  • Study protocol · Aug 4, 2025

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 8, 2026
Show all 1 update
  1. Oct 8, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07865104
Responsible party
Sponsor
First posted
Oct 8, 2026
Start date
Dec 1, 2023
Primary completion
Aug 29, 2026
Completion
Aug 29, 2026
Last update
Oct 8, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion